Delivery Order SPE2DB24D2003-SPE2DB24FXFA4
Award Date
6/13/24
Potential Completion Date
6/14/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of XCOPRI 50 MG TABLET 30S. This $1,271.47 award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of $1,623.99 worth of XCOPRI 100 MG TABLET 30S. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
The Defense Logistics Agency (DLA) awarded a $1,623.99 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XCOPRI 100 MG TABLET 30S. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department...
The U.S. government has awarded a Delivery Order contract worth $5,894.80 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of the pharmaceutical product XCOPRI 50 MG TABLET 30S. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA, which serves as a primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,623.99 to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XCOPRI 200 MG TABLET 30S. This delivery order has a completion date of February 28, 2024 and was awarded on February 27, 2024. Amerisourcebergen Drug Corp is a for-profit organization and holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XCOPRI 200 MG TABLET 30S. The contract has a completion date of January 30, 2024, and a potential value of $1,701.81. Amerisourcebergen Drug Corp, a for-profit organization, has received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and related...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,630.25, is a Delivery Order for the supply of XCOPRI 100 MG TABLET 30S, a medical product. The contract has a firm fixed price and an ultimate completion date of February 18, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $1,768.44, is for the delivery of XCOPRI 150 MG TABLET 30S, a specialty pharmaceutical product. The contract does not have a set-aside designation, indicating it was an open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,709.34 firm fixed price contract is for the supply of 30-count tablets of the pharmaceutical product XCOPRI 100 MG. The ultimate completion date is September 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the DLA to...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,083.48 firm-fixed-price contract is for the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and Amerisourcebergen, which covers the provision of a comprehensive range of medical commodities...